Janus Henderson Group PLC lifted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO) by 49.4% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,439,873 shares of the medical instruments supplier’s stock after purchasing an additional 476,327 shares during the period. Janus Henderson Group PLC owned approximately 3.92% of AngioDynamics worth $24,607,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in ANGO. Municipal Employees Retirement System of Michigan grew its holdings in shares of AngioDynamics by 13.3% in the second quarter. Municipal Employees Retirement System of Michigan now owns 8,160 shares of the medical instruments supplier’s stock valued at $132,000 after purchasing an additional 960 shares in the last quarter. Great West Life Assurance Co. Can grew its holdings in AngioDynamics by 10.9% during the 2nd quarter. Great West Life Assurance Co. Can now owns 48,226 shares of the medical instruments supplier’s stock worth $781,000 after acquiring an additional 4,737 shares in the last quarter. Texas Permanent School Fund grew its holdings in AngioDynamics by 8.0% during the 2nd quarter. Texas Permanent School Fund now owns 24,980 shares of the medical instruments supplier’s stock worth $405,000 after acquiring an additional 1,851 shares in the last quarter. Schwab Charles Investment Management Inc. grew its holdings in AngioDynamics by 44.9% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 339,972 shares of the medical instruments supplier’s stock worth $5,511,000 after acquiring an additional 105,414 shares in the last quarter. Finally, Arizona State Retirement System grew its holdings in AngioDynamics by 7.2% during the 2nd quarter. Arizona State Retirement System now owns 17,796 shares of the medical instruments supplier’s stock worth $288,000 after acquiring an additional 1,200 shares in the last quarter. Hedge funds and other institutional investors own 95.23% of the company’s stock.
Shares of AngioDynamics, Inc. (ANGO) traded up $0.07 during trading on Friday, reaching $16.35. 144,893 shares of the company’s stock were exchanged, compared to its average volume of 253,090. The stock has a market cap of $598.22, a P/E ratio of -77.85, a P/E/G ratio of 1.57 and a beta of 1.04. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.65 and a current ratio of 2.56. AngioDynamics, Inc. has a 52 week low of $14.80 and a 52 week high of $18.85.
AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.16. The business had revenue of $86.70 million during the quarter, compared to the consensus estimate of $88.15 million. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The business’s revenue was down 2.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.19 EPS. equities analysts anticipate that AngioDynamics, Inc. will post 0.69 EPS for the current year.
Several research analysts have commented on the stock. Canaccord Genuity reiterated a “hold” rating and set a $17.00 price target on shares of AngioDynamics in a report on Sunday, October 8th. TheStreet cut shares of AngioDynamics from a “b-” rating to a “c” rating in a report on Tuesday, January 2nd. Zacks Investment Research upgraded shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $18.00 target price for the company in a report on Monday, January 8th. Craig Hallum cut shares of AngioDynamics from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Finally, KeyCorp restated a “hold” rating on shares of AngioDynamics in a report on Friday, September 29th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $18.40.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2018/01/14/angiodynamics-inc-ango-stake-boosted-by-janus-henderson-group-plc.html.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.